Molecular nexopathies: A new paradigm of neurodegenerative disease

Trends in Neurosciences

Volumn 36, Issue 10, 2013, Pages 561-569

  Warren, Jason D ^a   Rohrer, Jonathan D ^a   Schott, Jonathan M ^a   Fox, Nick C ^a   Hardy, John ^b   Rossor, Martin N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dementia; Neural network; Neurodegeneration; Nexopathy

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; EVOLUTION; GAIN OF FUNCTION MUTATION; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEFECT; PROTEIN FUNCTION; REVIEW;

DEMENTIA; NEURAL NETWORK; NEURODEGENERATION; NEXOPATHY;

ANIMALS; HUMANS; NERVE NET; NEURODEGENERATIVE DISEASES;

EID: 84884815089     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2013.06.007     Document Type: Review

References (103)

1. Hagmann P., et al. Mapping the structural core of human cerebral cortex. PLoS Biol. 2008, 6:e159.
2. Bullmore E., Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 2009, 10:186-198.
3. Palop J.J., et al. A network dysfunction perspective on neurodegenerative diseases. Nature 2006, 443:768-773.
4. Pievani M., et al. Functional network disruption in the degenerative dementias. Lancet Neurol. 2011, 10:829-843.
5. Catani M. From hodology to function. Brain 2007, 130:602-605.
6. Modha D.S., Singh R. Network architecture of the long-distance pathways in the macaque brain. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:13485-13490.
7. Seeley W.W., et al. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009, 62:42-52.
8. Raj A., et al. A network diffusion model of disease progression in dementia. Neuron 2012, 73:1204-1215.
9. Zhou J., et al. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron 2012, 73:1216-1227.
10. Small D.H. Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?. Trends Mol. Med. 2008, 14:103-108.
11. Filippi M., Agosta F. Structural and functional network connectivity breakdown in Alzheimer's disease studied with magnetic resonance imaging techniques. J. Alzheimers Dis. 2011, 24:455-474.
12. Hughes L.E., et al. Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy. Neuroimage Clin. 2013, 2:459-468.
13. Gardner R.C., et al. Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann. Neurol. 2013, 73:603-616.
14. Scahill R.I., et al. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:4703-4707.
15. Warren J.D., et al. The paradox of syndromic diversity in Alzheimer disease. Nat. Rev. Neurol. 2012, 8:451-464.
16. Rohrer J.D., et al. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia. Neurology 2010, 75:2204-2211.
17. Rohrer J.D., et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage 2010, 53:1070-1076.
18. Rohrer J.D., et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 2011, 134:2565-2581.
19. Mackenzie I.R., et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011, 122:111-113.
20. Whitwell J.L., Josephs K.A. Neuroimaging in frontotemporal lobar degeneration; predicting molecular pathology. Nat. Rev. Neurol. 2012, 8:131-142.
21. Whitwell J.L., et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 2012, 135:794-806.
22. Whitwell J.L., et al. Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates. Neurobiol. Aging 2012, 34:636-639.
23. Agosta F., et al. Neuroimaging findings in frontotemporal lobar degeneration spectrum of disorders. Cortex 2012, 48:389-413.
24. Tsuji H., et al. Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain 2012, 135:3380-3391.
25. Collinge J., Clarke A.R. A general model of prion strains and their pathogenicity. Science 2007, 318:930-936.
26. Frost B., Diamond M.I. Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 2010, 11:155-159.
27. Bak T.H., Chandran S. What wires together dies together: verbs, actions and neurodegeneration in motor neuron disease. Cortex 2012, 48:936-944.
28. Nussbaum J.M., et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature 2012, 485:651-655.
29. Garden G.A., La Spada A.R. Intercellular (mis)communication in neurodegenerative disease. Neuron 2012, 73:886-901.
30. Warren J.D., et al. Disintegrating brain networks: from syndromes to molecular nexopathies. Neuron 2012, 73:1060-1062.
31. Baker H.F., et al. Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol. Neurobiol. 1994, 8:25-39.
32. Meyer-Luehmann M., et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006, 313:1781-1784.
33. Eisele Y.S., et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 2010, 330:980-982.
34. Schott J.M., et al. Apolipoprotein E genotype modifies the phenotype of Alzheimer disease. Arch. Neurol. 2006, 63:155-156.
35. Agosta F., et al. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2018-2022.
36. Lace G., et al. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain 2009, 132:1324-1334.
37. Grove E.A., Fukuchi-Shimogori T. Generating the cerebral cortical area map. Annu. Rev. Neurosci. 2003, 26:355-380.
38. Jessell T.M., Sanes J.R. Development. The decade of the developing brain. Curr. Opin. Neurobiol. 2000, 10:599-611.
39. Dasen J.S., et al. A Hox regulatory network establishes motor neuron pool identity and target-muscle connectivity. Cell 2005, 123:477-491.
40. Double K.L., et al. Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?. Prog. Neurobiol. 2010, 92:316-329.
41. Milanesi E., et al. Molecular signature of disease onset in Granulin mutation carriers: a gene expression analysis study. Neurobiol. Aging 2013, 34:1837-1845.
42. Zawia N.H., Basha M.R. Environmental risk factors and the developmental basis for Alzheimer's disease. Rev. Neurosci. 2005, 16:325-337.
43. Mesulam M.M. Defining neurocognitive networks in the BOLD new world of computed connectivity. Neuron 2009, 62:1-3.
44. Wickens J.R., et al. Effects of local connectivity on striatal function: stimulation and analysis of a model. Synapse 1995, 20:281-298.
45. Zappone C.A., Sloviter R.S. Commissurally projecting inhibitory interneurons of the rat hippocampal dentate gyrus: a colocalization study of neuronal markers and the retrograde tracer Fluoro-gold. J. Comp. Neurol. 2001, 441:324-344.
46. Somogyi P., Klausberger T. Defined types of cortical interneurone structure space and spike timing in the hippocampus. J. Physiol. 2005, 562:9-26.
47. Roberts G.W., et al. On the origin of Alzheimer's disease: a hypothesis. Neuroreport 1993, 4:7-9.
48. McMillan P., et al. Tau isoform regulation is region- and cell-specific in mouse brain. J. Comp. Neurol. 2008, 511:788-803.
49. Hara M., et al. Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology. Acta Neuropathol. 2013, 125:565-579.
50. Zhang B., et al. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J. Neurosci. 2004, 24:4657-4667.
51. Ikeda M., et al. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. Am. J. Pathol. 2005, 166:521-531.
52. Lobsiger C.S., Cleveland D.W. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci. 2007, 10:1355-1360.
53. Mesulam M.M. From sensation to cognition. Brain 1998, 121:1013-1052.
54. Shimizu T. Information flow and emergence of the global patterns in connected neural networks. Phys. A 2004, 333:478-496.
55. De Haan W., et al. Activity dependent degeneration explains hub vulnerability in Alzheimer's disease. PLoS Comput. Biol. 2012, 8:e1002582.
56. Kang J.E., et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009, 326:1005-1007.
57. Winklhofer K.F., et al. The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J. 2008, 27:336-349.
58. Wirths O. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol. 2006, 111:312-319.
59. Fransson P., Marrelec G. The precuneus/posterior cingulate cortex plays a pivotal role in the default mode network: Evidence from a partial correlation network analysis. Neuroimage 2008, 42:1178-1184.
60. Saavedra S., et al. Strong contributors to network persistence are the most vulnerable to extinction. Nature 2011, 478:233-235.
61. Gee D.G., et al. Low frequency fluctuations reveal integrated and segregated processing among the cerebral hemispheres. Neuroimage 2011, 54:517-527.
62. Halliday G., et al. Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects. Acta Neuropathol. 2012, 124:373-382.
63. Li Z., Dayan P. Computational differences between asymmetrical and symmetrical networks. Network 1999, 10:59-77.
64. Smeal R.M., et al. Phase-response curves and synchronized neural networks. Philos. Trans. R. Soc. B 2010, 365:2407-2422.
65. Devenport D., Fuchs E. Planar polarization in embryonic epidermis orchestrates global asymmetric morphogenesis of hair follicles. Nat. Cell Biol. 2008, 10:1257-1268.
66. Posada A., Clarke P.G. The role of neuronal death during the development of topographically ordered projections: a computational approach. Biol. Cybern. 1999, 81:239-247.
67. Piscopo P., et al. Hypoxia induces up-regulation of progranulin in neuroblastoma cell lines. Neurochem. Int. 2010, 57:893-898.
68. Beck J., et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008, 131:706-720.
69. Whitwell J.L., et al. Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN. Neurology 2011, 77:393-398.
70. Kertesz A., et al. The evolution and pathology of frontotemporal dementia. Brain 2005, 128:1996-2005.
71. Brettschneider J., et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013, 10.1002/ana.23937.
72. Polymenidou M., Cleveland D.W. The seeds of neurodegeneration: prion-like spreading in ALS. Cell 2011, 147:498-508.
73. Agosta F., et al. Resting state fMRI in Alzheimer's disease: beyond the default mode network. Neurobiol. Aging 2012, 33:1564-1578.
74. Whitwell J.L., et al. Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD. Neurology 2011, 77:866-874.
75. Rohrer J.D., et al. Tracking progression in frontotemporal lobar degeneration: serial MRI in semantic dementia. Neurology 2008, 71:1445-1451.
76. Chiong W., et al. The salience network causally influences default mode network activity during moral reasoning. Brain 2013, 136:1929-1941.
77. Jessell T.M., et al. Carbohydrates and carbohydrate-binding proteins in the nervous system. Annu. Rev. Neurosci. 1990, 13:227-255.
78. Seung H.S. Reading the book of memory: sparse sampling versus dense mapping of connectomes. Neuron 2009, 62:17-29.
79. Salehi A., et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 2006, 51:29-42.
80. Woo N.H., Lu B. Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist 2006, 12:43-56.
81. Grant S.G. Synapse signalling complexes and networks: machines underlying cognition. Bioessays 2003, 25:1229-1235.
82. Paraoanu L.E., Layer P.G. Acetylcholinesterase in cell adhesion, neurite growth and network formation. FEBS J. 2008, 275:618-624.
83. Pietri M., et al. Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells. J. Biol. Chem. 2006, 281:28470-28479.
84. Shen W., et al. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 2008, 321:848-851.
85. Aguzzi A., Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 2009, 64:783-790.
86. Hardy J., Revesz T. The spread of neurodegenerative disease. N. Engl. J. Med. 2012, 366:2126-2128.
87. Clavaguera F., et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 2009, 11:909-913.
88. Frost B., et al. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 2009, 284:12845-12852.
89. Liu L., et al. Trans-synaptic spread of tau pathology in vivo. PLoS ONE 2012, 7:e31302.
90. De Calignon A., et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012, 73:685-697.
91. Volpicelli-Daley L.A., et al. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011, 72:57-71.
92. Dunning C.J., et al. Can Parkinson's disease pathology be propagated from one neuron to another?. Prog. Neurobiol. 2012, 97:205-219.
93. Whitwell J.L., et al. Rates of cerebral atrophy differ in different degenerative pathologies. Brain 2007, 130:1148-1158.
94. Acosta-Cabronero J., et al. Atrophy, hypometabolism and white matter abnormalities in semantic dementia tell a coherent story. Brain 2011, 134:2025-2035.
95. Goll J.C., et al. Nonverbal sound processing in semantic dementia: a functional MRI study. Neuroimage 2012, 61:170-180.
96. Braak H., Del Tredici K. Alzheimer's pathogenesis: is there neuron-to-neuron propagation?. Acta Neuropathol. 2011, 121:589-595.
97. Von Gunten A., et al. Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease. Brain Res. Rev. 2006, 51:176-211.
98. Guest W.C., et al. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit. J. Toxicol. Environ. Health A 2011, 74:1433-1459.
99. Shi Y., et al. Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat. Neurosci. 2012, 15:477-486.
100. Lambon Ralph M.A., et al. Coherent concepts are computed in the anterior temporal lobes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2717-2722.
101. Rohrer J.D., et al. GENFI: The GENetic Frontotemporal dementia Dement Initiative. Dement. Geriatr. Cogn. Disord. 2012, 34(Suppl. 1):1-289.
102. Feigin A., et al. Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19559-19564.
103. Graf R.A., Kater S.B. Inhibitory neuronal activity can compensate for adverse effects of beta-amyloid in hippocampal neurons. Brain Res. 1998, 786:115-121.